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Rev1 contributes to proper 
mitochondrial function via the 
PARP-NAD+-SIRT1-PGC1α axis
Nima Borhan Fakouri1, Jon Ambæk Durhuus1, Christine Elisabeth Regnell2,4, Maria Angleys1, 
Claus Desler1, Mahdi Hasan- Olive2, Ana Martín-Pardillos3, Anastasia Tsaalbi-Shtylik3, 
Kirsten Thomsen4, Martin Lauritzen4,5, Vilhelm A. Bohr1,6, Niels de Wind3, Linda Hildegard 
Bergersen2,4 & Lene Juel Rasmussen1
Nucleic acids, which constitute the genetic material of all organisms, are continuously exposed to 
endogenous and exogenous damaging agents, representing a significant challenge to genome stability 
and genome integrity over the life of a cell or organism. Unrepaired DNA lesions, such as single- and 
double-stranded DNA breaks (SSBs and DSBs), and single-stranded gaps can block progression of the 
DNA replication fork, causing replicative stress and/or cell cycle arrest. However, translesion synthesis 
(TLS) DNA polymerases, such as Rev1, have the ability to bypass some DNA lesions, which can 
circumvent the process leading to replication fork arrest and minimize replicative stress. Here, we show 
that Rev1-deficiency in mouse embryo fibroblasts or mouse liver tissue is associated with replicative 
stress and mitochondrial dysfunction. In addition, Rev1-deficiency is associated with high poly(ADP) 
ribose polymerase 1 (PARP1) activity, low endogenous NAD+, low expression of SIRT1 and PGC1α and 
low adenosine monophosphate (AMP)-activated kinase (AMPK) activity. We conclude that replication 
stress via Rev1-deficiency contributes to metabolic stress caused by compromized mitochondrial 
function via the PARP-NAD+-SIRT1-PGC1α axis.
DNA is continuously challenged by endogenous DNA damaging agents, including reactive oxygen species (ROS) 
and reactive aldehydes, that are present in normal cells under normal physiological conditions. It has been esti-
mated that more than 10,000 oxidative DNA lesions arise spontaneously per mammalian cell per day1,2. Many 
types of endogenous DNA damage are quickly removed by base excision repair (BER), nucleotide excision repair 
(NER), mismatch repair (MMR) or double strand break repair (DSBR)3 pathways. However, DNA lesions that 
persist due to inefficient repair can be mutagenic, and/or can inhibit DNA replication/transcription, trigger apop-
tosis, cell cycle arrest or cellular senescence, or activate the DNA damage response (DDR) pathway4. Recent 
studies demonstrate that constitutive DDR consumes a large amount of energy in the form of adenosine triphos-
phate (ATP) and/or nicotinamide adenine dinucleotide (NAD+), such that chronic replicative stress is frequently 
associated with metabolic stress caused by energy imbalance or poor energy homeostasis5–7. Constitutive activa-
tion of DDR also creates a vicious cycle, as it can increase the abundance of ROS, which in turn generates more 
oxidative DNA lesions8. A key enzyme in DDR is poly(ADP) ribose polymerase 1 (PARP1), whose high consump-
tion of intracellular NAD+ can contribute to depletion of this important metabolite and lead to mitochondrial 
dysfunction9–11.
When a cell’s capacity to repair DNA lesions is exceeded, persistent DNA lesions arise, some of which block 
the progression of DNA replication forks. Typically, a cell responds by activating additional origins of replication, 
or by activating translesion synthesis (TLS)4 DNA polymerases, such as Rev1. Rev1 belongs to the Y-family of 
DNA polymerases, enzymes that carryout post-replication gap-filling DNA synthesis using a lesion-containing 
DNA strand as a template for the TLS reaction12,13. Rev1 also recruits other TLS polymerases to sites of DNA 
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damage14–16. TLS gene mutations and sequence variants are involved in many human neurological disorders as 
well as cancer17–20.
In Saccharomyces cerevisiae, The first 148 amino acids of Rev1 are sufficient to direct the localization of GFP to 
the mitochondria of yeast and Rev1 is thought to play a role in mutagenesis in that organelle21. In Rev1-deficient 
mouse embryo fibroblasts (Rev1−/− MEFs), ssDNA gaps accumulate during DNA replication13 and over time, 
proliferating tissues and stem cells are depleted in Rev1−/− mice relative to wild type (WT) controls22. Rev1−/− 
mice also have a growth defect13,23. To date, defects in Rev1 have not been linked to mitochondrial dysfunction 
in mammalian cells.
This study provides evidence that Rev1 is required for normal mitochondrial function and energy homeostasis 
in mouse cells. Furthermore, data presented here suggest that Rev1−/− MEFs express increased levels of constitu-
tively activated PARP1, reduced levels of endogenous NAD+, reduced expression of SIRT1 and PGC1α, reduced 
adenosine monophosphate (AMP)-activated kinase (AMPK) activity, and reduced autophagy and mitophagy. We 
conclude that replication stress caused by Rev1-deficiency contributes to cellular and organismal metabolic stress 
via mitochondrial dysfunction involving the PARP-NAD+-SIRT1-PGC1α axis7.
Results
In S. cerevisiae Rev1 localizes to the mitochondria, where it is thought to participate in replication and mutagen-
esis of the mitochondrial genome (mtDNA)21,24,25. Our past studies also suggest that S. cerevisiae Rev1, as well 
as Rev3, and Rev7, plays a role in mitochondrial-mediated mutagenesis26. The goal of the present study was to 
explore if Rev1 plays a role in mitochondrial function in mammalian cells.
Mitochondrial function is impaired in Rev1−/− cells. While the subcellular localization of murine 
Rev1 has not been determined, several reports indicate that human Rev1 is predominantly a nuclear protein27,28. 
Results presented in Fig. 1a suggest that murine Rev1 localizes predominantly to the nucleus. However, it might 
still affect mitochondrial functions.
Mitochondrial parameters were measured in primary liver cells from 5 month old WT and Rev1−/− mice 
(Figure S1) and in WT and Rev1−/− MEFs (Figs. 1c–e). Standard measures of electron transport chain (ETC) 
activity and oxidative phosphorylation (OXPHOS) were performed in an extracellular flux analyzer (Seahorse); 
these parameters were similar in WT and Rev1−/− liver tissue (Figures S1a, S1b); however, citrate synthase (CS) 
activity was lower in Rev1−/− liver tissue compared to WT (Fig. 1b). In contrast the basal respiration rate was 
approximately 30% higher in Rev1−/− MEFs than in WT MEFs (Fig. 1c). In MEFs treated with oligomycin to 
inhibit ATP synthase (complex V), respiration was 52% of basal respiration in WT and 46% of basal respiration 
in Rev1−/− cells (Fig. 1d). One interpretation is that ATP production is increased in Rev1−/− MEFs compared to 
WT MEFs29. The results also showed that reserve capacity was approximately 25% lower in Rev1−/−MEFs than 
in WT MEFs (Fig. 1e). This suggests that loss of Rev1 may impair mitochondrial functions29. A constant increase 
in mitochondrial activity associates with increased mitochondrial membrane potential (MMP) and ROS pro-
duction8. Membrane potential and ROS were elevated in Rev1−/− MEFs (Fig. 1f,g, S6), although the level of ROS 
increased gradually over 3 weeks in culture. The latter increase was not observed in WT MEFs (Fig. 1g).
Cellular stress and increased demand for ATP can lead to increases in respiration and MMP30,31. To assess 
this, ATP abundance was measured in WT and Rev1−/− MEFs (Fig. 1h). The results showed that total ATP was 
approximately 2-fold lower in Rev1−/− MEFs than in WT MEFs. This could reflect either decreased synthesis and/
or increased consumption of ATP.
The expression of SOD2 is decreased in Rev1−/− MEFs. Superoxide dismutase 2 (SOD2) is a mito-
chondrial matrix protein that converts highly reactive superoxide (O2•−) to less reactive hydrogen peroxide 
(H2O2), thereby protecting proteins, lipids, and DNA from oxidative damage8,32,33. Interestingly, SOD2 pro-
tein expression was decreased in Rev1−/− MEFs compared to WT MEFs (Fig. 1i). This could contribute to the 
increased abundance of ROS in the mitochondria of Rev1−/− cells8,34. Decreased SOD2 would also be expected to 
increase sensitivity of Rev1−/− cells to oxidative stress. Menadione is a quinone, which is metabolized and reduced 
to semi-quinone by flavoprotein within the mitochondrial inner membrane. In the presence of molecular oxygen, 
it enters the redox cycle to generate ROS such as superoxide anion radicals, H2O2, and Hydroxyl radical, which 
can induce oxidative stress in cells (Figure S2)34,35. Consistent with this prediction, Rev1−/− MEFs were more 
sensitive to menadione (5 to 20 μM) than WT MEFs (Fig. 1j), as measured by survival in a colony formation 
assay. The results also show that lower concentrations of menadione increase survival in WT MEFs, but not in 
Rev1-deficient MEFs (Fig. 1j).
Mitochondrial OXPHOS proteins are more abundant in Rev1-deficient cells. We investigated the 
mitochondrial content by analyzing the abundance of selected OXPHOS subunits and mtDNA content in WT 
and Rev1−/− liver tissue and MEFs. The results showed that complex I, II and III proteins are more abundant 
and mtDNA content is higher in Rev1−/− MEFs than in WT MEFs (Fig. 2a–c). In liver cells from female mice, 
complex II (SDHB) and complex IV (COXIV) were significantly higher in Rev1−/− than in WT (Figure S3a), 
with a general trend towards increased expression of all respiratory complexes in liver from Rev1-deficient mice. 
However, some data on liver tissue from male mice were not statistically significant (Figs 2f,g, S3a,b). The increase 
in mtDNA content in the liver of Rev1−/− mice is also not statistically significant (P = 0.089) (Figs 2h, S3c). In 
addition, expression of PGC1α was significantly lower in Rev1−/− MEFs than in WT MEFs (Fig. 2d,e), but signif-
icantly higher in liver cells from female Rev1−/− mice (Figures S3d and S5). Increased mitochondrial content was 
shown to be associated with a decrease in PGC1a and mitophagy36 We, therefore, tentatively conclude that the 
mitochondrial biogenesis is lower in Rev1-deficient MEFs, but higher in the liver of 5 months old Rev1−/− mice 
(Figs 2f,i, S3d).
www.nature.com/scientificreports/
3SCIeNtIfIC RePORTS | 7: 12480  | DOI:10.1038/s41598-017-12662-3
Figure 1. Mitochondrial function is impaired in Rev1−/− Cells. (a) Fluorescent microscopy analysis of 
subcellular localization of Rev1 protein. Rev1−/− MEFs transfected with plasmid containing Rev1-YFP fusion 
protein. MitoTracker Red and DAPI were used to visualize mitochondria and nucleus respectively (Size bar: 
5 μM). (b) CS activity in the liver of 5 months old WT and Rev1−/− mice. (c–e) Basal and ATP linked respiration 
and reserve capacity in WT and Rev1−/− MEF cells (n = 5). Basal respiration was calculated and normalized 
to the protein content (t = 4.808; df = 4). ATP linked respiration and reserve capacity were measured upon the 
injection of oligomycine (0.3 μM) and FCCP (1.5 μM) respectively. ATP linked respiration (t = 3.875; df = 4) 
and reserve capacity (t = 11.68; df = 4) are represented as relative decrease and increase in OCR, respectively, 
compared to basal respiration. (f,g) Flow cytometry analysis of MMP and mitochondrial ROS in WT and 
Rev1−/− MEF cells. The MMP was measured 3 weeks after initiation of cell culture (n = 4; t = 3.29; df = 3). The 
mitochondrial ROS was measured after 10 days and again after 3 weeks (n = 3; t = 9.777; df = 2). (h) The relative 
ATP level in WT and Rev1−/− MEFs after 3 weeks (n = 3; t = 11.7 df = 2). (i) Expression of SOD2 (mnSOD) 
in WT and Rev1−/− MEFs (n = 3). (j) Colony forming assay, cells treated with increasing concentrations of 
menadione. Colonies were stained with crystal violate and counted after one week of growth. n = sample 
number; t = t value; df = degree of freedom; *p < 0.05. **p < 0.01. ***p < 0.001. ****p < 0.0001. Data 
presented are mean ± M.S.E. Dark bars: WT and gray bars: Rev1−/−.
www.nature.com/scientificreports/
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Figure 2. Mitochondrial content and biogenesis. (a,b,f,g) Immunoblot analysis of the subunits of 
mitochondrial complexes in MEF cells (n = 5; df = 4) (a,b) and in liver (n = 5; df = 8) (f,g). (b,g) Quantifications 
of Cmpl. I-V protein levels from (A) MEFs and (f) liver, respectively. Cmpl. I (NDUFB8, NADH dehydrogenase 
1 beta subcomplex subunit 8) (MEFs: t = 4.981; Liver: t = 1.17); Cmpl. II: SDHB (Succinate dehydrogenase 
iron-sulfur subunit) (MEFs: t = 3.685; Liver: t: 2.23); Cmpl. III: UQCRC2 (Cytochrome b-c1 complex subunit 
2) (MEFs: t = 5.411; Liver: 2.383); Cmpl. IV: MTCO1 (Cytochrome c oxidase subunit 1) (MEFs: t = 2.378); 
COXIV (Cytochrome c oxidase subunit 4) (Liver: t = 4.79); Cmpl. V: ATP5A (ATP synthase subunit alpha) 
(MEFs: t = 2.302; Liver: t = 1.806). (c,h) Analysis of mtDNA content number by qPCR in MEF cells (n = 4; 
t = 3.544; df = 3) (c) and liver (n = 5; t = 1.944; df = 8) (h). The mtDNA content was calculated as the mtDNA/
nDNA ratio using primers specific for the mitochondrial TrnL1and nuclear β-2-microglobulin (β2M) genes. 
(d) Immunoblot analysis of PGC1α in MEFs (n = 7; t = 5.764; df = 6). (e) Quantification of PGC1α protein 
levels from (d) MEFs. (i) Quantification of PGC1α protein level in the liver of WT and Rev1−/− 5 months old 
mice (t = 1.761). n = sample number; t = t value; df = degree of freedom; *p < 0.05. **p < 0.01. ***p < 0.001. 
****p < 0.0001. Data presented are mean ± M.S.E.
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Altered mitochondrial morphology and decreased mitophagy in Rev1−/− cells. Change in 
mitochondrial morphology may reflect altered mitochondrial bioenergetics and/or increased energy demand37. 
Here, we compared mitochondrial morphology in WT and Rev1−/− MEFs and hepatocytes using Transmission 
Electron Microscopy (TEM) (Fig. 3a,b). We observed fragmented and elongated mitochondria in Rev1−/− hepat-
ocytes and MEFs at a much greater frequency than in WT cells, where mitochondria were more homogenous in 
size and shape. One explanation might be that surveillance and maintenance of the mitochondrial pool is less 
efficient in Rev1-deficient cells; another possibility is that the rates of mitochondrial fission/fusion and/or mito-
phagy/autophagy are altered in Rev1−/− cells30,38–40.
Autophagy is an intracellular process by which dysfunctional cellular components are degraded via the action 
of lysosomes. The rate of autophagy increases in response to starvation, growth factor deprivation, endoplasmic 
reticulum (ER) stress, infection, and other forms of stress41. Microtubule-associated protein 1 A/1B-light chain 
3 (LC3)-related proteins are markers of autophagy, because of their critical roles in this pathway41. Cells initially 
synthesize the unprocessed polypeptide LC3-I, which is converted to LC3-II during the final stage of autophagy. 
Therefore, the rate at which LC3-I is converted to LC3-II reflects the rate of autophagy42. Here, we observed 
that the deduced rate of autophagy was similar in liver cells from WT and Rev1−/− female mice (Fig. 4a,b), but 
appeared to be higher in liver cells from Rev1−/− male mice than in control cells (Fig. 4a,b). Autophagy and mito-
phagy was also measured in MEFs after exposure to rotenone (2 or 4 μ μM) (Fig. 4e,f). Rotenone is a mitochon-
drial toxin, which inhibits complex I activity and induces mitochondrial specific autophagy (mitophagy)36. There 
Figure 3. Analysis of mitochondrial morphology in MEF cells and liver hepatocytes. The TEM images of 
mitochondrial morphology in WT and Rev1−/− MEF cells after 8 passages (a) and hepatocytes of 5 months old 
mice (b). Size bars: 2 µM.
www.nature.com/scientificreports/
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Figure 4. Analysis of autophagy and mitochondrial dynamics in MEFs and hepatocytes in WT and Rev1−/− 
cells. (a) Analysis of autophagy by immunoblot and (b) quantification of LC3B-II/Actin ratio in the liver 
of WT and Rev1−/− 5 months old mice (females, n = 3; males n = 2). (c) Immunoblot analysis of total and 
phosphorylated DRP1 (Ser616) in the liver of WT and Rev1−/− 5 months old mice (male and females together, 
n = 5). (d) Quantification of total and phosphorylated DRP1 (Ser616) from panel (c). (e) Immunoblot with WT 
and Rev1−/− MEF cells, treated with rotenone (0 μM, 2 µM and 4 µM) for 12 hrs (n = 3; df = 2). (f) The LC3B-II/
Actin ratio in untreated and treated MEF cells after 12 hrs (0 µM: t = 1, 2 µM: t = 2.2, 4 µM: t = 14). (g,h) Analysis 
of total DRP1 (0 µM: t = 0.56; 2 µM: t = 5.1; 4 µM: t = 7.36) and phosphorylated DRP1 (Ser616) (0 µM: t = 3.96; 
2 µM: t = 21.93; 4 µM: t = 14.14) in untreated and treated MEFs. (i,j) Analysis of total AMPKα (0 µM: t = 2.09; 
2 µM: t = 0.56; 4 µM: 81.52) and phospho- AMPKα (Thr172) (0 µM: t = 64.37; 2 µM: t = 21.2; 4 µM: t = 4.67) 
in untreated and treated MEFs. n = sample number; t = t value; df = degree of freedom; *p < 0.05. **p < 0.01. 
***p < 0.001. ****p < 0.0001. Data presented are mean ± M.S.E. Dark bars: WT and gray bars: Rev1−/−.
www.nature.com/scientificreports/
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were no significant differences in autophagy flux between untreated WT and Rev1−/− MEFs. Untreated Rev1−/− 
cells showed a slight increase in autophagy (Fig. 4f). In response to treatment with rotenone, the expression and 
conversion of LC3B-I to LC3B-II was decreased in Rev1−/− cells, while it was increased in WT cells (Fig. 4e,f). 
To confirm this decrease in mitophagy in Rev1−/− MEF cells, we assessed the intensity of mitophagy specific dye 
using confocal microscopy in live cells after treatment with rotenone (see methods for details) and observed that 
the intensity of mitophagy marker is significantly higher (P < 0.0001) in WT cells compared to Rev1−/− MEFs 
(Figure S7). This suggests that stress-induced mitophagy may be impaired in Rev1-deficient cells.
The rate of mitochondrial fission was also examined in WT and Rev1-deficient cells43. Fission is a process 
through which mitochondria divide and give raise to smaller mitochondria. DRP1 is a GTPase member of the 
dynamin family, that oligomerizes on the surface of the outer mitochondrial membrane and promotes mitochon-
drial fission44,45. DRP1 is regulated via phosphorylation at Ser616 by cyclin dependent kinase (CDK1)/Cyclin 
B, which stimulates DRP1 activity and promotes efficient distribution of mitochondria to daughter cells dur-
ing mitosis46. We measured total and Ser616-phosphorylated DRP1 (pDRP1 Ser616) (Fig. 4c–e) and observed a 
higher level of total DRP1 but a lower level of p-DRP1 Ser616 in the liver cells from Rev1−/− mice (Fig. 4c,d). This 
result is consistent with suppressed DRP1 activity, less frequent mitochondrial fission and the presence of elon-
gated mitochondria in Rev1-deficient cells. In contrast, DRP1 expression was similar in WT and Rev1−/− MEFs. 
However, in response to treatment with rotenone, the total DRP1 protein is decreased in Rev1−/− MEFs while it 
increased in WT (Fig. 4e,g). p-DRP1 Ser616 was higher in untreated Rev1−/− than in untreated WT MEFs. The 
level of pDRP1 Ser616 increased significantly in rotenone treated WT and Rev1−/− MEFs and these changes were 
greater in treated Rev1−/− MEFs than in WT. We tentatively conclude that among the multiple factors that regu-
late mitochondrial dynamics and autophagy in MEFs, several are influenced by Rev1 genotype47,48.
Phosphorylation of AMPKα is decreased in Rev1−/− cells. AMPK positively regulates autophagy 
through its ability to inhibit mechanistic target of rapamycin (mTOR), a negative regulator of autophagy. However, 
AMPK also phosphorylates ULK1 and Raptor, which promotes autophagy47,49–51. Active DRP1 binds to the mito-
chondrial fission receptor (MFF) and phosphorylation of MFF by AMPK is required for the oligomerization of 
DRP1 on the mitochondrial outer membrane51. In addition, AMPK is sensitive to the AMP:ATP ratio, and is 
considered to be a “metabolic sensor.” When the AMP:ATP ratio increases, the AMPK catabolic subunit, AMPKα 
is phosphorylated by LKB1 on Thr172, which stimulates its kinase activity. Activated AMPK phosphorylates 
downstream targets to decrease ATP consumption and promote mitochondrial biogenesis and ATP production47.
Here, we observed that while expression of AMPKα was higher the abundance of pAMPKα Thr172 was 
significantly lower in Rev1−/− cells (Fig. 4e,i,j). 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an 
analog of adenosine monophosphate (AMP) that stimulates AMPK activity. Therefore, WT and Rev1-deficient 
cells were treated with AICAR, and the effect on mitochondrial bioenergetics was investigated (Figure S4). The 
results show no significant change in basal- or ATP-linked respiration in Rev1−/− or WT MEFs treated with 
AICAR relative to untreated controls. However, reserve capacity increased significantly in WT MEFs but 
decreased in Rev1−/− MEFs relative to untreated cells. These data are consistent with the idea that Rev1-deficient 
cells display mitochondrial dysfunction and a defect in autophagy, which could reflect de-regulation of upstream 
signals including LKB1 and Sirtuin-1 (SIRT1).
Rev1-deficiency affects mitochondrial function through PARP-NAD+-SIRT1-PGC1α axis. 
SIRT1 is a class III histone deacetylase (HDAC), which requires NAD+ for activity. Deacetylation of target pro-
teins by SIRT1 can either enhance or decrease their activity or stability52. SIRT1 deacetylates a number of target 
proteins including LKB1 and PGC1α. Deacetylation of LKB1 by SIRT1 promotes its activity and the phospho-
rylation of AMPK α at Thr17252–55. We investigated expression of SIRT1 in WT and Rev1−/− MEFs and observed 
decreased abundance of SIRT1 in Rev1−/− MEFs (Fig. 5a,b) as well as a significantly lower level of NAD+ in 
Rev1−/− MEFs than in WT MEFs (Fig. 5c). These data suggest that low abundance of SIRT1 and NAD+ leads to 
low AMPK activity in Rev1-deficient cells.
PARP1 is a component of DDR that detects and binds to abnormal and damaged DNA9,10,56. Upon binding, 
PARP1 synthesizes and attaches poly(ADP-ribose) polymers (PAR) on its protein substrates. PARP1 also auto-
PARylates itself, thus, PARP1 can be a major consumer of intracellular NAD+10,56,57 and it can impair mitochon-
drial function58. The PARP1 expression is significantly increased in Rev1−/− MEFs (Fig. 5d,e). To test whether 
decrease in NAD+ level is responsible for mitochondrial dysfunction in Rev1−/− cells, we treated the MEF cells 
with 3 mM Nicotinamide riboside (NR), a NAD+ precursor (Figure S8). NR treatment enhanced mitochondrial 
function and increased the reserve capacity to the level of untreated Rev1+/+ cells. This suggests that impaired 
mitochondrial function in Rev1+/+ cells is caused by NAD+ depletion and NR supplement can suppress this 
defect.
Here, we propose that defects in Rev1 could increase the load of persistent DNA lesions and thus lead to 
constitutive activation of PARP1. It has previously been proposed that such a pathway reflects “nuclear to mito-
chondrial DNA damage signaling”7. Our results are consistent with activation of such a pathway in Rev1-deficient 
cells, because the abundance of PARP1 is significantly higher in Rev1−/− MEFs than in WT MEFs (Fig. 5d,e).
Discussion
This study examines whether and how murine Rev1 might play a direct role in or modulate mitochondrial func-
tion(s) and cellular bioenergetics. Our data are consistent with the idea that Rev1-deficiency leads to replicative 
stress, which may in turn lead to constitutive activation of DDR and PARP1, decreased abundance of NAD+, and 
low SIRT1 and AMPK activities. Similar observations were recently made in other DNA repair deficient cells, and 
this set of related observations was referred to in that context as the “PARP-NAD+-SIRT1-PGC1α axis”7 (Fig. 6).
www.nature.com/scientificreports/
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Rev1-deficient cells are unable to bypass the damaged bases and replication stress is higher in these cells59. 
Rev1−/− cells accumulate single stranded gaps opposite the DNA lesions, which induce DNA damage signaling 
and irreversible G2 arrest13. In response to DNA damage and DDR activation, cells increase mitochondrial respi-
ration and OXPHOS activity to increase ATP60.
The altered mitochondrial morphology, decreased mitophagy, increased basal and ATP linked respiration as 
well as increased MMP and mitochondrial ROS in Rev1−/− suggests that ATP production may be higher in these 
cells than in WT controls,30,31,37,61. However, we observed that total ATP was nearly 2-fold lower in Rev1−/− than 
in WT control cells. This indicates that ATP consumption exceeds ATP production in Rev1−/− MEFs as these cells 
are constantly under replication stress59. In addition, we observed that the PARP1 expression is increased and the 
NAD+ level is decreased in Rev1-deficient cells, which can impair mitochondrial function, mitophagy and ATP 
synthesis7,11,58. Interestingly, we could suppress the decreased mitochondrial reserve capacity in Rev1−/− MEFs by 
addition of the NAD+ precursor NR (Figure S8). This supports the axis, Fig. 6, where the decreased levels of NAD 
lead to mitochondrial dysfunction, and this can at least partially be restored by NAD supplementation.
Despite a significant decrease in abundance of ATP, AMPK activity was lower in Rev1−/− cells. This is an 
important observation, because AMPK is required to inhibit Akt–mTOR62,63, and to activate mitophagy/
Figure 5. Cellular SIRT1 protein and NAD+ levels are decreased while the PARP1 protein level is increased in 
Rev1−/− MEFs. (a) Immunoblot analysis of SIRT1 in MEFs in 6 biological replicates (n = 6; t = 3.457; df = 5). (b) 
Quantification of protein levels shown in panel (a). (c) Relative NAD+ (NAD+/NADH) level in WT and Rev1−/− 
MEFs (n = 6, t = 3.161, df = 10). (d) Immunoblot analysis of PARP1 in WT and Rev1−/− MEF cell extracts in 
several biological replicates (n = 5, t = 4.251, df = 4). (e) Quantification of protein levels shown in panel (d). 
n = sample number; t = t value; df = degree of freedom; *p < 0.05. **p < 0.01. ***p < 0.001. ****p < 0.0001. 
Data presented are mean ± M.S.E. Dark bars: WT and gray bars: Rev1−/−.
www.nature.com/scientificreports/
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autophagy in response to replicative or other forms of chronic stress. In addition, increased Akt activity negatively 
regulates the SOD2 expression64.
Despite a significant increase in total DRP1 and pDRP1 ser616 in Rev1-deficient MEFs, these cells appear 
to accumulate elongated mitochondria with aberrant morphological features. This could reflect the low level of 
activated AMPK in Rev-1 deficient cells, because activated AMPK stimulates MFF, promotes oligomerization 
of DRP1 on the surface of mitochondria, and stimulates mitophagy51. Decreased AMPKα phosphorylation can 
be explained by the decrease in SIRT1 protein level and perhaps its activity as NAD+ level was decreased in 
Rev1−/− MEFs53–55. As treatment with AICAR did not rescue mitochondrial dysfunction in Rev1-deficient cells, 
we conclude that signals downstream of AMPK, such as SIRT1 and LKB1, may be suppressed or dysfunctional 
in Rev1−/− MEFs.
In conclusion, the results presented here suggest that Rev1-deficient MEFs and liver tissue may experience 
persistent replication stress and DDR, which leads to metabolic stress caused by mitochondrial dysfunction, 
mediated by the so-called “PARP-NAD+-SIRT1-PGC1α axis”7 (Fig. 6). In addition, our results suggest that 
AMPK may also tie into the “PARP-NAD+-SIRT1-PGC1α axis”, and suppression of its activity could exacerbate 
mitochondrial dysfunction in these cells.
Materials and Methods
Animals and Cells. WT and Rev1−/− mice and MEF cells were provided by Dr. Niels de Wind from the 
department of human genetics at Leiden University Medical Center (LUMC). All procedures involving animals 
were approved by the Danish National Ethics Committee according to the guidelines set forth in the European 
Council’s Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific 
Purposes. Mice were randomized and marked with special ear cuts for later identification. WT and Rev1−/− mice 
and MEFs were genotyped as described before65. We excluded mouse 7 (due to being heterozygous) and 9 (for 
being sick and moribund) (Figure S5a). Sex determination by PCR in mice was performed as described66. Mice 
Figure 6. The “PARP-NAD+-SIRT1-PGC1α axis”. Replication stress can cause mitochondrial dysfunction 
by downstream changes in various cellular pathways. A number of factors contribute to this signaling, such as 
poly(ADP-ribose) polymerase 1 (PARP1), ataxia telangiectasia mutated (ATM), ataxia telangiectasia and Rad3-
related protein (ATR), and the transcription factor p53. The NAD-dependent protein deacetylase sirtuin 1 (SIRT1) 
and the transcription regulator AMP-activated protein kinase (AMPK) then propagate the signal through post-
translational modifications (deacetylation or phosphorylation, respectively) of peroxisome proliferator-activated 
receptor-γ co-activator 1α (PGC1α) and other proteins. The figure is adapted from Fang et al. 20167.
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were sacrificed by cervical dislocation and the liver, kidneys, heart and brain were removed. MEF cells cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) plus 10% (v/v) fetal calf serum (Invitrogen) and 100 U/mL penicil-
lin-streptomycin in a humidified atmosphere of 5% CO2 at 37 °C. All the experiments are carried out latest two 
weeks after the initiation of the cell culture or as stated.
Isolation of Mitochondria from the Mice Liver. Mitochondria from WT and Rev1−/− mice aged 5 
months were isolated by centrifugation methods as described67. The liver was extracted and sliced in MSHE+ 
BSA (4 °C), and all subsequent steps of the preparation were performed on ice. The material was rinsed sev-
eral times to remove blood. The tissue was disrupted using a drill-driven Teflon glass homogenizer with 2–3 
strokes. Homogenate was centrifuged at 800 × g for 10 min at 4 °C. Following centrifugation, fat/lipid was care-
fully removed, and the remaining supernatant was decanted through 2 layers of cheesecloth to a separate tube and 
centrifuged at 8000 × g for 10 min at 4 °C. After removal of the mitochondrial layer, the pellet was resuspended 
in MSHE+ BSA, and the centrifugation was repeated. The final pellet was resuspended in a minimal volume of 
MSHE+ BSA. Total protein (mg/ml) was determined using Bradford Assay reagent (Bio-Rad).
Cellular bioenergetics and citrate synthase assay. All XF assays were performed using an XF24 
Extracellular Flux Analyzer (Seahorse Bioscience):
MEF cells. Oxygen consumption rate and cellular acidification rate in MEF cells measured according to the 
manufacturer procedure. Briefly, 5 × 104 cells/well seeded on the seahorse plate 12 hrs before the experiment. For 
the AICAR treatment, cells were treated with AICAR (0.25 mM) for 96 hrs prior to the experiment. Total protein 
was extracted from the cells in each well and protein concentrations determined by Bradford. The basal respira-
tion was normalized to the protein content of each well.
Isolation of mitochondria from liver. Respiration of isolated liver mitochondria was determined with a Seahorse 
XF24 Analyzer. The isolation procedure was performed on ice. Liver was excised and immersed in ice-cold mito-
chondrial isolation buffer (MSHE; in mM: sucrose 70; mannitol 210; HEPES 5 and EGTA 1, pH 7.0) + 0.5% (w/v) 
fatty acid-free BSA and homogenized in a dounce type teflon-on-glass homogenizer. The homogenate was centri-
fuged 5 min at 900×g. The supernatant was collected, while avoiding top layer of fat, and transferred to Eppendorf 
tubes and centrifuged for 10 min at 9000×g. Following centrifugation, fat was carefully removed and pellet was 
resuspended in MSHE buffer where after the suspension was centrifuged for 10 min at 10,000×g. The pellet was 
re-suspended in MSHE. Protein concentration was determined spectrophotometrically at 595 nm by addition of 
5 μl diluted mitochondrial suspension and 250 μl Bio-Rad (Hercules, CA, USA) Protein Assay Dye reagent. BSA 
was used as standard protein.
Determination of parameters of oxidative phosphorylation of isolated liver mitochondria. The suspension of iso-
lated mitochondria was diluted in supplemented MSHE (10 mM succinate +2 μM rotenone for coupling assay 
and 10 mM pyruvate +2 mM malate +4 μM FCCP for electron flow assay) and added to a final concentration of 
5 μg to each well in a 24-well Seahorse plate. The plate was centrifuged at 2,000×g for 10 min at RT. Mitochondrial 
assay solution (MAS; in mM: sucrose 70; mannitol 220; KH2PO4 10; MgCl2 5; HEPES 2 and EGTA 1; pH 7.0) was 
added and the plate was transferred to the XF24 Seahorse at 37 °C. For monitoring mitochondrial respiration the 
measurement cycle consisted of 1 min mixing and one measurement cycle (each measurement cycle reflects an 
average of ten measurements) before addition of first inhibitor/substrate compound (40 mM ADP for coupling 
assay, 20 µM rotenone for electron flow assay), then another measurement cycle and injection of second com-
pound (3 μM oligomycin for coupling assay, 0.1 M succinate for electron flow assay), and another two cycles after 
injection of third compound (4 µM FCCP for coupling assay, 40 μM antimycin A for electron flow assay), and 
fourth compound (40 μM antimycin A for coupling assay, 100 mM ascorbate +1 mM TMPD for electron flow 
assay) respectively. Each point represents an average of a minimum of 3 replicate wells and each condition was 
repeated a minimum of 5 times.
Citrate synthase activity assay on liver homogenate. The citrate synthase activity (CS) assay was determined as 
described68 with minor modifications. All steps were done on ice and centrifugation steps at 4 °C. Liver tissue was 
immersed in ice cold MSHE buffer after excision, and washed with MSHE buffer to remove blood. The liver tissue 
was snap frozen in liquid nitrogen and stored at −80 °C. 30–50 mg of tissue was used for CS assay. Visible fat was 
removed and liver tissue was minced with scissors before dilution in 5 ml MSHE +0.5% fatty acid free BSA buffer 
in a 1-ml douncer with a teflon-on-glass homogenizer. The homogenate was centrifuged at 10 min for 600×g, and 
the supernatant was transferred to a new tube and centrifuged at 10 min for 7000×g. The supernatant was discarded 
and pellet resuspended in remaining buffer. In a 1-ml quartz cuvette the following things were mixed: 300 μl dis-
tilled water, 500 μl Tris (200 mM, pH 8.0) with 0.2% Triton X-100 (v/v), 100 μl DTNB (5,5′-Dithiobis(2-nitrobenzoic 
acid, 1mM), 30 μl of Acetyl-coenzyme A lithium salt (10 mM) and 60 μg liver tissue. The baseline activity was read at 
absorbance 412 nm for 2 min, hereafter the reaction was started by 50 μl of oxaloacetic acid 10 mM, and the increase 
in absorbance was monitored for 3 min. Activity was measured as ((ΔAbsorbance/min) × 1000)/(13.6 × sam-
ple(ml) × protein concentration (mg/ml). All the reagents were from Sigma-Aldrich.
Isolation of genomic DNA and mtDNA quantification. Genomic DNA (gDNA), RNA and pro-
tein were extracted from snap frozen tissues in liquid nitrogen, using Norgen Biotik RNA/DNA Purification 
Kit (Cat. 48700) according to the manufacturer’s protocol. Quantitative PCR (two independent reactions) was 
used for measurement of mtDNA69 using SYBR Green PCR Master mix (Applied Biosystems). The mtDNA 
copy number normalized to nuclear DNA was measured as the ratio of DNA encoding the mitochondrial 
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gene for murine tRNA leucine 1 (Trnl1) to DNA encoding the nuclear gene encoding Beta-2 microglobulin 
(B2m). The following primers were used: B2m forward, 5′-GTCAGATATGTCCTTCAGCAAG-3′, and reverse, 
5′-CTTcAACTCTGCAGGCGTATG-3′; and Trnl1 forward, 5′-AAGGTTATTAGGGTGGCAG-3′, and reverse, 
5′-GGACGAGGAGTGTTAGGATA-3′. For PCR reaction mixture 5 ng of genomic DNA was mixed with 2 μl of 
each primers (5 μM), 10 μl SYBR green and 0.4 μl ROX and nuclease free water to the final volume of 20 μl. All 
reactions were run in triplicates. The relative mtDNA levels were calculated using formula 2 × 2ΔCT.
Immunoblot analysis. The frozen liver tissues were ground in liquid nitrogen prior to incubation with RIPA 
(Sigma) supplemented with supplemented with cOmplete™, EDTA-free Protease Inhibitor Cocktail (Sigma) and 
PhosSTOP phosphatase inhibitor Cocktail (Sigma). MEFs cells and grinded tissue were re-suspended in RIPA 
(Sigma) supplemented with supplemented with cOmplete™, EDTA-free Protease Inhibitor Cocktail (Sigma) and 
PhosSTOP phosphatase inhibitor Cocktail (Sigma). The cell suspension was left on ice for 30 min followed by 
sonication and then left on ice for another 15 min. Subsequently, the cell suspension was centrifuged at 20K 
G-force for 20 min and the supernatant was mixed with NuPAGE® LDS Sample Buffer (4X) (Thermo Fisher 
Scientific). For gel electrophoresis, the supernatants was denatured at 70 °C (50 °C for mitochondrial complexes 
analyses) for 10 min and 20 to 30 μg protein was loaded on NuPAGE™ Novex™ 4–12% Bis-Tris Protein Gels, 
1.0 mm (Thermo Fisher Scientific) and run according to the manufacturer’s instructions.
Antibodies used in this study: pan-Actin (Thermo Fisher Scientific MA5-11869) (1:20000); AMPKα1 (Santa 
Cruz bio. Sc-19128) (1:500); Phospho-AMPKα (Thr172)(Cell signaling #2531) (1:1000); COX4 (Santa Cruz 
bio. Sc-69360) (1:2000); DRP1 (Cell signaling #8570) (1:1000); Phospho-DRP1 (Ser616) (Cell signaling #3455) 
(1:1000); Lamin B1 (Abcam ab133741) (1:10000); LC3B/MAP1LC3B (Novus Biologicals, NB100-2220) (1:1000); 
Total OXPHOS Rodent WB Antibody Cocktail (Abcam, ab110413) (1:1000); PARP (Cell signaling, #9542) 
(1:1000); PGC1α (Novus Biologicals, NBP1-04676) (1:3000); SIRT1 (Santa Cruz bio, sc-15404) (1:500); SOD2 
(Cell signaling, #13194) (1:1000).
Measurements mitochondrial membrane potential and ROS. Mitochondrial membrane potential 
and ROS were measured as described elsewhere using MitoSOX Red and TMRM (Thermo Fisher Scientific) 
respectively70. Briefly, 0.7 × 105 cells/well were seeded in six well plates less than 48 hrs before initiation of the 
experiment. Cells were washed with Dulbecco’s Phosphate-Buffered Saline (DPBS) and treated with 5 µM 
MitoSOX Red for 15 min and 40 µM TMRM for 20 min prior to FACS analysis. MitoSOX Red-positive cells 
were counted using a FACScanTM flow cytometer (Becton Dickinson). For live cell fluorescent imaging of MMP, 
approximately 2 × 105 cells/6cm culture dish seeded 24h before the experiment. Treated cell were incubated with 
2 µM rotenone for 5h in complete medium. After treatment cells were washed with PBS and incubated with 40 
nM TMRM in serum free medium for 30 minutes. After staining cells were washed and incubated with serum free 
media for live cell imaging using confocal microscopy (Zeiss Confocal microscope LSM 780).
ATP and NAD+/NADH Quantitation. ATP concentration was detected using an ATPlite Luminescence 
Assay System (PerkinElmer) according to the manufacturer’s instruction. Briefly, cells were plated in a 96-well 
plate (105 cells in 100 ml/well) for 24 hrs before the ATP consumption assay. After this time, 50 µl lysis buffer was 
added followed by addition of substrate. Luminescence was measured on the FLUOstar OPTIMA Microplate 
reader (BMG LABTECH). Measurement of NAD+ is performed using SIGMA NAD/NADH Quantitation kit 
(MAK037) according to the manufacturer protocol. Briefly, 2 × 104 cells harvested for total NAD extraction and 
quantification. The NAD Cycling Enzyme Mix in the kit recognizes NADH and NAD, but not NADP or NADPH, 
in an enzyme cycling reaction. Concentration of NAD total (NADt) (NAD+ + NADH) is determined by meas-
uring the absorbance at (OD 450 nm). The NAD+ concentration is calculated by subtracting the NADH values 
from NADt. In Some Rev1−/− samples, the NADH concentration was below the detection range. We perceived 
the NADH concentration in these samples as zero (0).
Colony forming assay. For the cell survival assay, 700 cells were seeded in 100 mm culture dishes. After 
24 hrs, different concentrations of menadione (0, 5, 10, 15, and 20 μM) were added to the cell culture. The cultures 
were maintained until colonies were visible. The colonies were then fixed and stained with crystal violate in 20% 
ethanol, and colonies with more than 50 cells, were counted as a colony.
Detection of Autophagy and Mitophagy. Analysis of autophagy/mitophagy was carried out by detecting 
the LC3-II/actin ratio71. Briefly, 7 × 105 cells/dish were seeded on 10 cm cell culture dishes. The following day, 
mitophagy was induced by treatment with 2 and 4 μM rotenone for 12 hrs. After this time, cells were harvested and 
prepared for immunoblotting. We used a commercially mitophagy kit (Dojindo Laboratories) to assess the rate 
of mitophagy as described by provider. About 2 × 105 cells were seeded on cover slips in 6 cm culture dishes 24 h 
before the live imaging. The next day, cells were washed twice with PBS and serum free media. The mitophagy dye 
diluted to the recommended working concentration (100 nM/l) in serum free media and cells incubated for 30 min. 
The media and dye was removed and cells were washed twice with PBS and serum free media. Next, Cells were 
incubated with complete media containing 2 µM rotenone for 5h. After 5h, the intensity of mitophagy dye was asses 
using confocal microscopy (Zeiss Confocal microscope LSM 780). Pictures were analyzed using image J software.
Transfection, fluorescence microscopy. Transfection of the YFP-Rev1 fusion protein into Rev1−/− MEF 
cells was performed using Lipofectamine® 3000 reagent (Life technologies) according to the manufacturer pro-
cedure. Briefly, 3 × 105 cells/well were seeded in 6 well plates 18 hrs before the transfection. Cells were transfected 
with 2.5 μg of plasmid DNA per well in complete medium. Transfected cells were visualized with an inverted 
fluorescence microscope (Nikon). MitoTracker staining (Molecular Probes) was performed in live MEFs and 
analyzed by fluorescent microscopy after fixation with 4% formaldehyde.
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Electron microscopy. Mice Livers. For transmission electron microscopy studies small blocks (typically 
0.5 mm × 0.5 mm × 1 mm) from the liver from WT and Rev1−/− mice, perfusion-fixed with 4% paraformaldehyde 
and 0.1 glutaraldehyde in phosphate buffer were cryoprotected in glycerol and freeze substituted with Lowicryl 
HM20 as described72. Ultrathin sections were cut (90 nm) using a diamond knife and dried at room temperature 
followed by counterstaining with 1% uranyl acetate and 0.3% lead citrate. Electron micrographs were taken with 
a FEI Tecnai 12 transmission electron microscope at primary magnifications of ×6000.
MEF Cells. Cells were seeded on the Thermanox™ coverslips (Thermoscientific) in 12 well plates at the con-
centration of 5 × 104 cells/well. When the cells became confluent, they were washed with PBS, and fixed in 2% 
glutaraldehyde/0.1 M sodium cacodylate buffer (pH 7.4) at room temperature for 1 hr. Cells were washed twice in 
PBS and postfixed in 2% OsO4/PBS at room temperature for 1 hr, dehydrated in ethanol and embedded in Epon 
(Serva, Heidelberg, Germany). Thin sections of 50 nm were contrasted with uranylacetate and lead citrate, and 
examined using a transmission electron microscope (Tecnai G2 20 TWIN).
Statistical analysis. Prism 7.0 (GraphPad Software) was used to plot data, make graphs, and statistical anal-
ysis. Data are plotted as mean ± SEM. Two-tailed paired and unpaired Student’s t-test was performed for MEFs 
and liver cells.
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